Chitosan-based nanoformulated (–)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis

Chitosan-based nanoformulated (–)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis

Jean Christopher Chamcheu,1,2,* Imtiaz A Siddiqui,1,* Vaqar M Adhami,1,* Stephane Esnault,3 Dhruba J Bharali,4 Abiola S Babatunde,1,5 Stephanie Adame,1 Randall J Massey,6 Gary S Wood,1 B Jack Longley,1 Shaker A Mousa,4 Hasan Mukhtar11Department of Dermatology, School of Medicine and Public...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chamcheu JC, Siddiqui IA, Adhami VM, Esnault S, Bharali DJ, Babatunde AS, Adame S, Massey RJ, Wood GS, Longley BJ, Mousa SA, Mukhtar H
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Chitosan nanoparticles
topical delivery of chitosan nanoformulated EGCG
psoriasis-like skin inflammation
phytochemical treatment of psoriasis
normal human epidermal keratinocytes
differentiation
anti-inflammatory action.
Medicine (General)
R5-920
Acceso en línea:https://doaj.org/article/53eec2a944e449b39137010fdacb57e5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/53eec2a944e449b39137010fdacb57e5

Ejemplares similares